EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials

Brian G Murphy iD, Diego Castillo, N E Neely iD, Amir Kol, Terza Brostoff iD, Chris K Grant, Krystle L Reagan iD

Viruses · 2024

DOI: 10.3390/v16030462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Brian G Murphy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA. Hauptthemen laut MEDLINE: Feline Infectious Peritonitis, Coronavirus Infections, Coronavirus, Feline. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, SOCK-FIP fund of the Center for Companion Animal Health at University of California, Davis, School of Veterinary Medicine, UC Davis Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Feline infectious peritonitis (FIP) is a multisystemic, generally lethal immuno-inflammatory disease of domestic cats caused by an infection with a genetic variant of feline coronavirus, referred to as the FIP virus (FIPV). We leveraged data from four different antiviral clinical trials performed at the University of California, Davis. Collectively, a total of 60 client-owned domestic cats, each with a confirmed diagnosis of naturally occurring FIP, were treated with a variety of antiviral compounds. The tested therapies included the antiviral compounds GS-441524, remdesivir, molnupiravir and allogeneic feline mesenchymal stem/stroma cell transfusions. Four client-owned cats with FIP did not meet the inclusion criteria for the trials and were not treated with antiviral therapies; these cats were included in the data set as untreated FIP control cats. ELISA and Western blot assays were performed using feline serum/plasma or ascites effusions obtained from a subset of the FIP cats. Normalized tissue/effusion viral loads were determined in 34 cats by a quantitative RT-PCR of nucleic acids isolated from either effusions or abdominal lymph node tissue. Twenty-one cats were PCR “serotyped” (genotyped) and had the S1/S2 region of the coronaviral spike gene amplified, cloned and sequenced from effusions or abdominal lymph node tissue. In total, 3 untreated control cats and 14 (23.3%) of the 60 antiviral-treated cats died or were euthanized during (13) or after the completion of (1) antiviral treatment. Of these 17 cats, 13 had complete necropsies performed (10 cats treated with antivirals and 3 untreated control cats). We found that anticoronaviral serologic responses were persistent and robust throughout the treatment period, primarily the IgG isotype, and focused on the viral structural Nucleocapsid and Membrane proteins. Coronavirus serologic patterns were similar for the effusions and serum/plasma of cats with FIP and in cats entering remission or that died. Viral RNA was readily detectable in the majority of the cats in either abdominal lymph node tissue or ascites effusions, and all of the viral isolates were determined to be serotype I FIPV. Viral nucleic acids in cats treated with antiviral compounds became undetectable in ascites or abdominal lymph node tissue by 11 days post-treatment using a sensitive quantitative RT-PCR assay. The most common pathologic lesions identified in the necropsied cats were hepatitis, abdominal effusion (ascites), serositis, pancreatitis, lymphadenitis, icterus and perivasculitis. In cats treated with antiviral compounds, gross and histological lesions characteristic of FIP persisted for several weeks, while the viral antigen became progressively less detectable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feline Infectious PeritonitisCoronavirus InfectionsCoronavirus, FelineHumansCatsAnimalsAscitesRNA, ViralAntiviral Agents

Stichwörter der Autor:innen

FIPantiviral compoundcatfeline coronavirusserology

Substanzen

RNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
  • School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
  • Custom Monoclonals International, 813 Harbor Boulevard, West Sacramento, CA 95691, USA.
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

ORCID-Profile: Brian G Murphy, N E Neely, Terza Brostoff, Krystle L Reagan

Förderung

  • NICHD NIH HHS
  • SOCK-FIP fund of the Center for Companion Animal Health at University of California, Davis, School of Veterinary Medicine
  • UC Davis Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis
  • National Institute of Child Health and Human Development
  • EveryCat Health Foundation
  • BestFriends Animal Sanctuary
  • UC Davis Veterinary Center for Clinical Trials Circle

Zitieren

APA

Murphy, B. G., Castillo, D., Neely, N. E., Kol, A., Brostoff, T., Grant, C. K., & Reagan, K. L. (2024). Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials. Viruses. https://doi.org/10.3390/v16030462

Vancouver

Murphy BG, Castillo D, Neely NE, Kol A, Brostoff T, Grant CK, et al. Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials. Viruses. 2024. doi:10.3390/v16030462

BibTeX
@article{Murphy2024,
  author = {Murphy, Brian G and Castillo, Diego and Neely, N E and Kol, Amir and Brostoff, Terza and Grant, Chris K and Reagan, Krystle L},
  title = {Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16030462}
}
Kostenlos starten →